Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction

A Hassan, BJ Hunt, M O'Sullivan, R Bell, R D'Souza… - Brain, 2004 - academic.oup.com
Cerebral small vessel disease (SVD) causes focal lacunar infarction and more diffuse
ischaemia, referred to as leukoaraiosis. Endothelial dysfunction has been proposed as a causal …

Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis

A Hassan, BJ Hunt, M O'Sullivan, K Parmar… - Brain, 2003 - academic.oup.com
Patients with cerebral small vessel disease (SVD) can present as isolated lacunar infarction
or with diffuse white matter changes, with the imaging appearance of leukoaraiosis. …

Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes

…, S Gustafsson, J Haessler, TB Harris, A Hassan… - Nature …, 2018 - nature.com
Stroke has multiple etiologies, but the underlying genes and pathways are largely unknown.
We conducted a multiancestry genome-wide-association meta-analysis in 521,612 …

Genetics and ischaemic stroke

A Hassan, HS Markus - Brain, 2000 - academic.oup.com
Ischaemic stroke can be caused by a number of monogenic disorders, and in such cases
stroke is frequently part of a multisystem disorder. Cerebral autosomal dominant arteriopathy …

Risk factor profile of cerebral small vessel disease and its subtypes

U Khan, L Porteous, A Hassan… - Journal of Neurology …, 2007 - jnnp.bmj.com
Background: The mechanisms of cerebral small vessel disease (SVD) are unclear. Both
atherosclerosis and a non-atherosclerotic diffuse arteriopathy have been reported pathologically…

Evaluating the genetic component of ischemic stroke subtypes: a family history study

P Jerrard-Dunne, G Cloud, A Hassan, HS Markus - Stroke, 2003 - Am Heart Assoc
Background and Purpose— Twin and family history studies support a role for genetic factors
in stroke risk. Because the etiology of ischemic stroke is heterogeneous, genetic factors may …

[HTML][HTML] Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial

…, M Randall, T Thirugnana-Chandran, A Hassan… - The Lancet, 2019 - thelancet.com
Background Results of small trials indicate that fluoxetine might improve functional outcomes
after stroke. The FOCUS trial aimed to provide a precise estimate of these effects. Methods …

[HTML][HTML] Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies

…, C Price, A Barry, C Roffe, J Coyle, A Hassan… - The Lancet …, 2019 - thelancet.com
Background Cerebral microbleeds are a neuroimaging biomarker of stroke risk. A crucial
clinical question is whether cerebral microbleeds indicate patients with recent ischaemic stroke …

Isosorbide mononitrate and cilostazol treatment in patients with symptomatic cerebral small vessel disease: the lacunar intervention trial-2 (LACI-2) randomized …

…, V Cvoro, FN Doubal, T England, A Hassan… - JAMA …, 2023 - jamanetwork.com
Importance Cerebral small vessel disease (cSVD) is a common cause of stroke (lacunar
stroke), is the most common cause of vascular cognitive impairment, and impairs mobility and …

Characteristics and outcomes of COVID-19 associated stroke: a UK multicentre case-control study

…, R Marigold, M Willmot, A Dixit, A Hassan… - Journal of Neurology …, 2021 - jnnp.bmj.com
Objective We set out to determine which characteristics and outcomes of stroke are associated
with COVID-19. Methods This case-control study included patients admitted with stroke to …